Partnering to improve child psychiatry training, services in Uzbekistan

Professor of Psychiatry Mohammad Ghaziuddin will spend the next five months in the country on a Fulbright Scholarship

Author | Craig McCool

Mohammad Ghaziuddin in Uzbekistan
Dr. Ghaziuddin (left) with Fulbright program officials in the U.S. Embassy offices in Tashkent.

A Professor of Psychiatry is back in Uzbekistan for the second time in less than a year to help strengthen the country's youth mental health services. 

Mohammad Ghaziuddin, MD, who spent about a month in Uzbekistan last year laying the groundwork for a partnership, was awarded a Fulbright scholarship to return for five months this year to design and implement the country's first formal specialty training program for child psychiatry.

"Currently, there is no formal residency or fellowship training for child psychiatry, even though more than one third of the population is less than 18 years old," Ghaziuddin said. "So there is a growing need."

At present, certification courses are offered for psychiatrists who wish to specialize in treating children and adolescents. These courses take a few weeks to complete. Health leaders are looking to introduce a new model that more closely follows the residency and fellowship programs found in the West.

Ghaziuddin is partnering with collaborators from the Tashkent Pediatric Medical Institute, located in Uzbekistan's capital. Even before his arrival in February, he and his counterparts had been meeting on Zoom for months to begin writing a curriculum and planning for implementation. To start, they hope to enroll about five trainees per year.

Having previously worked to expand services in places like Ethiopia and Saudi Arabia, this marks Ghaziuddin's first time partnering in Central Asia. Once a part of the Soviet Union, Uzbekistan has been modernizing rapidly in recent years, with the government making significant investments in improving infrastructure and training more providers.

"There is a big transition taking place in this part of the world, so it is exciting to be here at this moment to witness some of these changes," Ghaziuddin said. "Our hope is that my visit will be a catalyst to help start a sustainable residency program and to help the Ministry increase awareness of child and adolescent psychiatry in general among doctors here."

Featured News & Stories headshot of Carrie Ferrario
Department News
Congratulations to Dr. Carrie Ferrario on her promotion to Full Professor with Tenure!
Congratulations to Dr. Carrie Ferrario on her promotion to Full Professor with Tenure!
Department News
Congratulations to Jacquelyn Roberts!
Jacquelyn (Melanie Ohi lab) successfully defended her thesis, "Cryo-EM Insights into the Architecture and Functional Resilience of the Legionella pneumophila Dot/Icm Type IV Secretion System," on Wednesday, May 14, 2025.
person looking at ipad with provider on screen smiling
Health Lab
Telemedicine had an impact on carbon emissions equivalent to reducing up to 130,000 car trips each month in 2023
Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of up to 130,000 gas operated vehicles, suggesting it could have a positive effect on climate change, UCLA and Michigan led research finds.
Headshots of five Biological Chemistry faculty promoted in 2025
Department News
Five Biological Chemistry faculty members receive promotions in 2025
Biological Chemistry faculty members Ryan Baldridge, PhD, Kevin Bohannon, PhD, Lydia Freddolino, PhD, Tobias Giessen, PhD, and Jeremy Schroeder, PhD, have been promoted.
headshot of Eric-Jiminez-Vazquez
Department News
Congratulations to Dr. Eric Jimenez Vazquez on his promotion to Assistant Research Scientist!
Congratulations to Dr. Eric Jimenez Vazquez on his promotion to Assistant Research Scientist!
hand holding in bed child hopsital
Health Lab
Researchers discover new protein target for childhood medulloblastomas
Group-3 medulloblastomas are aggressive and incurable, contributing to childhood cancer deaths. Led by University of Michigan researchers, a study identified a new target for Group-3 medulloblastomas. The results help identify new therapeutic avenues for treating these deadly tumors.